UK & EU public-sector contracts
Every live tender notice from Contracts Finder, Find a Tender, eTenders Ireland and TED — refreshed hourly, every record linking back to source.
Live now
8K
Value in flight
£664.6bn
Countries covered
56
On record
116K
Every live tender notice from Contracts Finder, Find a Tender, eTenders Ireland and TED — refreshed hourly, every record linking back to source.
This contract opportunity involves the establishment of non-exclusive discount agreements for finished pharmaceuticals containing the active ingredient Rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per divided oral dosage form) under an 'open-house model'. All eligible and interested ph
This contract opportunity involves establishing non-exclusive discount agreements for the medication Certolizumab pegol, as per § 130a Abs. 8 SGB V. The agreements will be made under an Open-House model, allowing all interested pharmaceutical companies to participate during the application period, p
This contract opportunity involves establishing non-exclusive discount agreements for pharmaceuticals containing the active ingredients Brinzolamid and Brimonidin (official ATC code: S01EC24) under the German Social Code. The agreements will be made through an Open-House model, allowing all interest
This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Rivaroxaban, specifically for film-coated tablets excluding the 2.5 mg strength. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the option for suppliers to e
The German health insurance companies and pharmaceutical companies can enter into framework discount agreements for medications covered by statutory health insurance, as permitted by § 130a paragraph 8 of the Social Code Book V. The DAK-Gesundheit will conduct a formal procurement process for the ac
This is not a standard procurement process but an open-house model for pharmaceutical companies. The AOK Bayern intends to establish non-exclusive discount agreements for the drug Leuprorelin (ATC L02AE02) with all interested pharmaceutical companies that meet the specified eligibility criteria. The
This announcement is for establishing agreements with pharmaceutical companies as per § 130a Abs. 8 Sentence 1 SGB V. The invitation to participate is directed only to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs as defined in § 4 Abs. 18 of the Medicines Act. This is
This announcement is for establishing agreements with companies or consortia of companies for blood glucose test strips in accordance with § 130a Abs. 8 Satz 1 of the Fifth Book of the Social Code (SGBV) for the state of North Rhine-Westphalia. The agreements will include discount contracts, allowin
This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Tramadol and Paracetamol, in accordance with German social law. The contracts will be valid from October 1, 2025, to September 30, 2027, and suppliers can enter into contracts at
This contract opportunity involves the establishment of non-exclusive discount contracts for medications containing the active ingredients Olodaterol and Tiotropium Bromide. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the possibility of entering into contracts a
This contract opportunity involves the development and operation of solar energy production facilities located in non-interconnected areas of France. Selected candidates, as designated by the Minister of Energy, will receive a remuneration contract for the electricity produced, in accordance with sp
This procurement project aims to establish a contract for maintenance services for MSR Neuberger at the locations of Oberpfaffenhofen and Augsburg. Suppliers are invited to provide their proposals for the maintenance and repair of electrical and mechanical systems in buildings. The goal is to ensure
This contract notice provides information about the individual contracts awarded through the Warwickshire County Council's Dynamic Purchasing System (DPS) for Employability and Skills for the first quarter of 2025. Suppliers can find detailed information about each awarded contract in the attached d
This contract notice provides information about the individual contracts awarded through the Dynamic Purchasing System (DPS) for Road Traffic Surveys for the first quarter of 2025. Suppliers can find detailed information about these contracts in the attached document. The DPS for Road Traffic Survey
Warwickshire County Council (WCC) is seeking suppliers for its Passenger Transport Service, which utilizes taxis or private hire cars. This contract covers individual routes awarded for the first quarter of 2025. Suppliers can find detailed information about the specific routes in the attached docum
This contract notice provides information about the awarded bus transport routes under the Warwickshire County Council (WCC) Dynamic Purchasing System (DPS) for the first quarter of 2025. Suppliers can find detailed information about the specific routes in the attached document. The Bus Transport Se
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interes
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred
The KKH (Kaufmännische Krankenkasse) is seeking to establish non-exclusive discount agreements with pharmaceutical companies for specific active ingredients under the Open-House procedure. This opportunity is open to all qualified pharmaceutical companies or groups of companies interested in enterin
The DAK-Gesundheit is seeking pharmaceutical companies to enter into a non-exclusive discount agreement for the drug Umeclidinium (ATC R03BB07) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from September 1, 2025, to August 31, 2027. The process will follow the formal